The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis
- 28 September 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 63 (6) , 1079-1080
- https://doi.org/10.1212/01.wnl.0000138572.82125.f5
Abstract
Oral prednisone 1might be a convenient, inexpensive alternative to IV methylprednisolone (IVMP) if the bioequivalent dose was known. We compared the total amount of steroid absorbed after 1250 mg oral prednisone vs 1 gram IVMP in 16 patients with multiple sclerosis (MS). At 24 hours, the mean area under the concentration-time curve (AUC), the main component of bioavailability, did not differ between groups (p = 0.122). This suggests that the amount of absorbed corticosteroid is similar after either steroid at these doses.Keywords
This publication has 8 references indexed in Scilit:
- Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosisNeurology, 1999
- Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosisThe Lancet, 1997
- Trials to assess equivalence: the importance of rigorous methodsBMJ, 1996
- The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple SclerosisNew England Journal of Medicine, 1993
- A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic NeuritisNew England Journal of Medicine, 1992
- High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical responseEuropean Journal of Clinical Pharmacology, 1992
- Influence of route of administration on the pharmacokinetics of methylprednisoloneJournal of Pharmacokinetics and Biopharmaceutics, 1983